CVAC vs. BNTX

Last updated Jul 21, 2026

CVAC (CureVac N.V.) and BNTX (BioNTech SE) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, CVAC returned -39.77%/yr vs -18.34%/yr for BNTX. At a 0.42 correlation, their price movements are largely independent.

Performance

CVAC vs. BNTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CureVac N.V. (CVAC) and BioNTech SE (BNTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CVAC achieves a 3.10% return, which is significantly higher than BNTX's -3.19% return.

CVAC

• 1D: 0.00%
• 1M: 0.00%
• 6M: 0.00%
• YTD: 3.10%
• 1Y: -13.54%
• 3Y*: -23.43%
• 5Y*: -39.77%
• 10Y*: —
• ALL TIME*: -31.66%

BNTX

• 1D: 0.74%
• 1M: 1.40%
• 6M: -15.45%
• YTD: -3.19%
• 1Y: -16.23%
• 3Y*: -5.32%
• 5Y*: -18.34%
• 10Y*: —
• ALL TIME*: 29.33%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CVAC vs. BNTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
CVAC CureVac N.V.	3.10%	32.55%	-19.00%	-30.18%	-82.42%	-57.68%	84.25%
BNTX BioNTech SE	-3.19%	-16.45%	7.97%	-29.74%	-40.40%	216.24%	14.82%

Correlation

The correlation between CVAC and BNTX is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.34
Correlation (3Y) Calculated over the trailing 3-year period	0.40
Correlation (5Y) Calculated over the trailing 5-year period	0.41
Correlation (All Time) Calculated using the full available price history since Aug 14, 2020	0.42

Fundamentals

Market Cap CVAC : $1.05B BNTX : $23.31B
Total Revenue (TTM) CVAC : €70.74M BNTX : €2.80B
Gross Profit (TTM) CVAC : €65.79M BNTX : €2.05B
EBITDA (TTM) CVAC : €181.23M BNTX : -€815.04M

Return for Risk

CVAC vs. BNTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CVAC

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

BNTX

BNTX Risk / Return Rank: 26
BNTX Sharpe Ratio Rank: 27
BNTX Sortino Ratio Rank: 27
BNTX Omega Ratio Rank: 27
BNTX Calmar Ratio Rank: 26
BNTX Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CVAC vs. BNTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CureVac N.V. (CVAC) and BioNTech SE (BNTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CVAC	BNTX	Difference
Sharpe ratio: Return per unit of total volatility	-0.75	-0.39	-0.36
Sortino ratio: Return per unit of downside risk	-0.82	-0.29	-0.53
Omega ratio: Gain probability vs. loss probability	0.78	0.96	-0.18
Calmar ratio: Return relative to maximum drawdown	-0.61	-0.55	-0.07
Martin ratio: Return relative to average drawdown	-1.32	-1.00	-0.32

CVAC vs. BNTX - Sharpe Ratio Comparison

The current CVAC Sharpe Ratio is -0.75, which is lower than the BNTX Sharpe Ratio of -0.39. The chart below compares the historical Sharpe Ratios of CVAC and BNTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CVAC vs. BNTX - Drawdown Comparison

The maximum CVAC drawdown since its inception was -98.30%, which is greater than BNTX's maximum drawdown of -82.08%. Use the drawdown chart below to compare losses from any high point for CVAC and BNTX.

Drawdown Indicators

	CVAC	BNTX	Difference
Max Drawdown Largest peak-to-trough decline	-98.30%	-82.08%	-16.22%
Max Drawdown (1Y) Largest decline over 1 year	-25.23%	-29.71%	+4.48%
Max Drawdown (3Y) Largest decline over 3 years	-75.45%	-37.35%	-38.10%
Max Drawdown (5Y) Largest decline over 5 years	-96.90%	-82.08%	-14.82%
Current Drawdown Current decline from peak	-96.58%	-78.92%	-17.66%
Average Drawdown Average peak-to-trough decline	-81.52%	-56.56%	-24.96%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.27%	16.29%	-4.02%

Volatility

CVAC vs. BNTX - Volatility Comparison

The current volatility for CureVac N.V. (CVAC) is 0.00%, while BioNTech SE (BNTX) has a volatility of 7.74%. This indicates that CVAC experiences smaller price fluctuations and is considered to be less risky than BNTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CVAC	BNTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.00%	7.74%	-7.74%
Volatility (6M) Calculated over the trailing 6-month period	18.79%	34.19%	-15.40%
Volatility (1Y) Calculated over the trailing 1-year period	20.55%	41.49%	-20.94%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	67.18%	54.79%	+12.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	74.89%	75.88%	-0.99%

Dividends

CVAC vs. BNTX - Dividend Comparison

Neither CVAC nor BNTX has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022
BNTX BioNTech SE	0.00%	0.00%	0.00%	0.00%	2.43%
CVAC CureVac N.V.	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both CVAC and BNTX in my portfolio?

CVAC and BNTX have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CVAC or BNTX?

BNTX has higher volatility (7.74%) compared to CVAC (0.00%). In terms of maximum drawdown, CVAC dropped -98.30% vs BNTX's -82.08%.

Which has better risk-adjusted returns?

BNTX currently has the higher Sharpe Ratio (-0.39 vs -0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.